Vertex Pharmaceuticals Statistics
NASDAQ: VRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
500.63-5.02 (-0.99%)
Market open · Delayed 15 min · as of Oct 8, 12:33 PM ET
Vertex Pharmaceuticals by the numbers
Vertex Pharmaceuticals has a market capitalization of $126.89 billion based on 253.46M shares outstanding. Its trailing P/E ratio is 29.2, above the 7-company peer median of 18.0, and its forward P/E is 24.9. The stock trades 3.6% below its 50-day average and 5.5% above its 200-day average.
Average daily trading volume is 1.16M shares, or about $579.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VRTX valuation vs. peer median
| Metric | VRTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $126.89B | $107.70B | +18% |
| P/E (TTM) | 29.2 | 18.0 | +62% |
| Forward P/E | 24.9 | 10.4 | +139% |
| Avg. volume | 1.16M | 6.66M | -83% |
Peer median across 8 companies: BMY, PFE, SNY, GSK, NVO, ABT, REGN, TAK.
Valuation
- Market cap
- $126.89B
- P/E (TTM)
- 29.16
- Forward P/E
- 24.89
- Price / sales (latest FY)
- 10.57
- EPS (TTM)
- $17.17
- Shares outstanding
- 253.46M
Price and trading
- Previous close
- 505.64
- Open
- 503.14
- Day range
- 498.90 – 507.87
- 52-week range
- 402.58 – 560.25
- 52-week change
- +23.24%
- 50-day moving average
- 519.50
- 200-day moving average
- 474.42
- Beta
- —
- Volume
- 433.11K
- Average volume
- 1.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 126.89B
- Pe
- 29.16
- Forward Pe
- 24.89
- Eps
- 17.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 560.25
- Week52 Low
- 402.58
- Avg Volume
- 1.16M
- Shares Outstanding
- 253.46M
- Ma50
- 519.50
- Ma200
- 474.42
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -10.64%
- Pct From52w Low
- 24.35%